These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2645767)

  • 21. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
    Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
    Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
    Bichet DG; Van Putten VJ; Schrier RW
    N Engl J Med; 1982 Dec; 307(25):1552-7. PubMed ID: 6755251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased renin release by exogenous prostaglandin E1 in liver cirrhosis with and without ascites.
    Uemasu J; Kawasaki H; Hirayama C
    Horm Metab Res; 1988 May; 20(5):302-5. PubMed ID: 3042580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
    Planas R; Ginès P; Arroyo V; Llach J; Panés J; Vargas V; Salmerón JM; Ginès A; Toledo C; Rimola A
    Gastroenterology; 1990 Dec; 99(6):1736-44. PubMed ID: 1699835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
    Salerno F; Badalamenti S; Lorenzano E; Moser P; Incerti P
    Hepatology; 1991 Apr; 13(4):707-13. PubMed ID: 1826281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
    Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
    J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
    Yang YY; Lin HC; Lin MW; Chu CJ; Lee FY; Hou MC; Lee SD; Lee WP; Liu TT; Jap TS
    Clin Sci (Lond); 2011 Dec; 121(11):509-21. PubMed ID: 21692745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
    García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
    Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
    Solà R; Vila MC; Andreu M; Oliver MI; Coll S; Gana J; Ledesma S; Ginès P; Jiménez W; Arroyo V
    J Hepatol; 1994 Feb; 20(2):282-8. PubMed ID: 7516361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
    Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
    Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.